• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用原始祖细胞培养及其克隆形成后代(CFU-GM)评估慢性粒细胞白血病中的“不一致成熟”

Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).

作者信息

Marley S B, Lewis J L, Scott M A, Goldman J M, Gordon M Y

机构信息

Leukaemia Research Fund Centre for Adult Leukaemia, Royal Postgraduate Medical School, London.

出版信息

Br J Haematol. 1996 Nov;95(2):299-305. doi: 10.1046/j.1365-2141.1996.d01-1910.x.

DOI:10.1046/j.1365-2141.1996.d01-1910.x
PMID:8904885
Abstract

The 'discordant maturation hypothesis' proposes that the most mature proliferating cells in chronic-phase chronic myeloid leukaemia (CML) are responsible for the expansion of the Ph-positive population. To evaluate this hypothesis we used a delta assay for primitive haemopoietic cells (P delta assay for P delta cells) which allows investigation of the kinetics of granulocyte-macrophage progenitor (CFU-GM) production. The frequencies of these primitive (P delta) cells were similar in CML blood (14.5/10(5) mononuclear cells), CML marrow (17.3/10(5)) and normal marrow (11.6/10(5)) The average frequency in normal blood is only 0.58/10(6). The absolute numbers of P delta cells in CML patients are therefore greatly increased. The average numbers of CFU-GM produced by individual P delta cells were reduced in CML blood (8.1) and marrow (11.6) compared with normal marrow (28.5). This is consistent with a reduced probability of differentiation at the single cell level in CML. Although the absolute number of CFU-GM produced by individual CML P delta cells was subnormal there was a relative increase in the number of day 7 CFU-GM compared with the number of day 14 and 21 CFU-GM, which agrees with the 'discordant maturation hypothesis'. This bias towards day 7 colony formation could reflect accelerated maturation by the CFU-GM produced by P delta cells or, alternatively, the production of CFU-GM with shorter than normal maturation pathways. Overall, these results suggest that discordant maturation does not by itself account for myeloid expansion in CML. It is more likely that myeloid expansion in CML is due mainly to an increase in the number of primitive haemopoietic progenitor cells.

摘要

“不一致成熟假说”提出,慢性期慢性髓性白血病(CML)中最成熟的增殖细胞是导致Ph阳性群体扩增的原因。为了评估这一假说,我们对原始造血细胞采用了一种δ检测法(Pδ细胞的Pδ检测法),该方法可用于研究粒细胞-巨噬细胞祖细胞(CFU-GM)产生的动力学。这些原始(Pδ)细胞的频率在CML血液(14.5/10⁵个单核细胞)、CML骨髓(17.3/10⁵)和正常骨髓(11.6/10⁵)中相似。正常血液中的平均频率仅为0.58/10⁶。因此,CML患者中Pδ细胞的绝对数量大幅增加。与正常骨髓(28.5)相比,CML血液(8.1)和骨髓(11.6)中单个Pδ细胞产生的CFU-GM平均数量减少。这与CML单细胞水平分化概率降低一致。尽管单个CML Pδ细胞产生的CFU-GM绝对数量低于正常水平,但与第14天和21天的CFU-GM数量相比,第7天CFU-GM的数量相对增加,这与“不一致成熟假说”相符。这种对第7天集落形成的偏向可能反映了Pδ细胞产生的CFU-GM成熟加速,或者是产生了成熟途径比正常短的CFU-GM。总体而言,这些结果表明,不一致成熟本身并不能解释CML中的髓系扩增。CML中的髓系扩增更可能主要是由于原始造血祖细胞数量增加。

相似文献

1
Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).利用原始祖细胞培养及其克隆形成后代(CFU-GM)评估慢性粒细胞白血病中的“不一致成熟”
Br J Haematol. 1996 Nov;95(2):299-305. doi: 10.1046/j.1365-2141.1996.d01-1910.x.
2
Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha.
Leuk Res. 1995 May;19(5):319-23. doi: 10.1016/0145-2126(94)00143-x.
3
Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM.在体外,α干扰素与阿糖胞苷(Ara-C)或全反式维甲酸(ATRA)联合使用可降低干扰素对慢性粒细胞白血病集落形成单位-粒细胞-巨噬细胞(CML CFU-GM)的选择性作用。
Leukemia. 2000 Aug;14(8):1396-400. doi: 10.1038/sj.leu.2401860.
4
Discordant maturation as the primary biological defect in chronic myelogenous leukemia.不协调成熟作为慢性粒细胞白血病的主要生物学缺陷。
Cancer Res. 1988 Feb 15;48(4):1035-41.
5
Probability of progenitor renewal (PPR) and production of clonogenic progeny (CFU-GM) by primitive adherent progenitor cells in adult human bone marrow and umbilical cord blood.成人骨髓和脐带血中原始贴壁祖细胞的祖细胞更新概率(PPR)及克隆形成子代(CFU-GM)的产生
Br J Haematol. 1995 Aug;90(4):744-9. doi: 10.1111/j.1365-2141.1995.tb05191.x.
6
Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.粒细胞-巨噬细胞集落刺激因子对转化生长因子-β抑制正常及白血病人类造血祖细胞作用的调节
Leukemia. 1992 Sep;6(9):886-92.
7
A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
Leuk Res. 1992;16(2):153-8. doi: 10.1016/0145-2126(92)90126-r.
8
Blast colony-forming cell binding from CML bone marrow, or blood, on stromal layers pretreated with G-CSF or SCF.慢性粒细胞白血病骨髓或血液中的原始集落形成细胞与经粒细胞集落刺激因子(G-CSF)或干细胞因子(SCF)预处理的基质层的结合。
Cell Prolif. 2002 Feb;35(1):1-7. doi: 10.1046/j.1365-2184.2002.00217.x.
9
The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.酪氨酸激酶抑制剂STI571与α干扰素一样,能优先降低慢性粒细胞白血病患者的粒细胞-巨噬细胞祖细胞的扩增能力。
Exp Hematol. 2000 May;28(5):551-7. doi: 10.1016/s0301-472x(00)00142-9.
10
Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.I型干扰素对造血祖细胞的不同作用:干扰素未能抑制IL-3刺激的正常和慢性粒细胞白血病髓系祖细胞
Exp Hematol. 1995 Dec;23(14):1431-8.

引用本文的文献

1
Biological consequences of the BCR/ABL fusion gene in humans and mice.人类和小鼠中BCR/ABL融合基因的生物学后果。
J Clin Pathol. 1999 Oct;52(10):719-22. doi: 10.1136/jcp.52.10.719.
2
Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.用α干扰素治疗可优先降低慢性粒细胞白血病患者粒细胞-巨噬细胞祖细胞(CFU-GM)的扩增能力,但不影响正常CFU-GM。
J Clin Invest. 1998 Aug 15;102(4):710-5. doi: 10.1172/JCI3094.